Technical Report Cardiac/Thoracic/Vascular Surgery
Does early enteral nutrition reduce surgical site infection in children with asthma? A quality-improvement audit

Does early enteral nutrition reduce surgical site infection in children with asthma? A quality-improvement audit

Authors

Mateo Lindqvist

Mateo Lindqvist

Toronto General Hospital, Afghanistan

Zainab Dubois

Zainab Dubois

Toronto General Hospital, Sao Tome and Principe

Clara Osei

Clara Osei

Toronto General Hospital, Gabon

Corresponding
Yusuf Silva

Yusuf Silva

Mayo Clinic, Niue

Published

June 17, 2026

Paper ID

PAP-000159

Status

Published

DOI

10.65712/tmj.test000417

Does early enteral nutrition reduce surgical site infection in children with asthma? A quality-improvement audit

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: surgical site infection remains a leading cause of avoidable harm among children with asthma. Methods: We conducted a quality-improvement audit across 9 centres between 2016 and 2022. Results: Effects were consistent across prespecified subgroups. Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.

Introduction

Guidelines make only a weak recommendation on early enteral nutrition.

Practice around early enteral nutrition varies widely between centres. Earlier studies of early enteral nutrition were small or single-centre.

Guidelines make only a weak recommendation on early enteral nutrition. Practice around early enteral nutrition varies widely between centres.

Practice around early enteral nutrition varies widely between centres. Guidelines make only a weak recommendation on early enteral nutrition. The cost of surgical site infection to health systems is substantial.

Discussion

Residual confounding cannot be excluded. Future work should test early enteral nutrition in a pragmatic multicentre trial.

Future work should test early enteral nutrition in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.

Residual confounding cannot be excluded. Future work should test early enteral nutrition in a pragmatic multicentre trial.

Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Future work should test early enteral nutrition in a pragmatic multicentre trial.

Strengths include the sample size and blinded outcome assessment. These findings suggest that early enteral nutrition is associated with better surgical site infection in children with asthma.

Conclusions

Early enteral nutrition may be offered for children with asthma to improve surgical site infection.

References

1. Kim Q, Kaur N, et al. Tranexamic acid and chronic pain scores. Pediatrics. 2024;177(6):462-1177.

2. Ahmed I, Silva H, et al. High-flow nasal oxygen and emergency department revisits. Diabetes Care. 2012;24(4):833-998.

3. Andersen B, Tanaka S, et al. Prone positioning and medication adherence. JAMA. 2022;362(4):838-1673.

4. Costa O, Rossi G, et al. Low-dose aspirin and health-related quality of life. BMJ. 2024;308(2):497-1245.

5. Zhang K, Mensah A, et al. Pharmacist-led medication review and patient satisfaction. Lancet. 2022;400(7):681-1730.

6. Lindqvist S, Okafor K, et al. Delayed cord clamping and acute kidney injury. BMC Med. 2013;291(1):897-1065.

7. Yilmaz E, Schmidt M, et al. Tranexamic acid and chronic pain scores. Eur Heart J. 2010;181(6):569-940.

8. Dubois P, Dubois W, et al. Prone positioning and glycaemic control. Diabetes Care. 2008;76(6):748-1544.

Appendices

Ethics approval: IRB-8754.

Materials and Methods

Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.

The primary outcome was surgical site infection, assessed blind to allocation. Missing data were handled with multiple imputation. Eligible participants were children with asthma.

Results

The adjusted odds ratio was 0.64 (95% CI 0.25 to 0.89). The adjusted odds ratio was 0.80 (95% CI 0.28 to 0.75). Serious adverse events were rare and similar between groups. surgical site infection occurred in 21% of the intervention group versus 31% of controls.

surgical site infection occurred in 17% of the intervention group versus 29% of controls. surgical site infection occurred in 22% of the intervention group versus 20% of controls.

The adjusted odds ratio was 0.76 (95% CI 0.23 to 0.60). surgical site infection occurred in 20% of the intervention group versus 37% of controls.

GroupnEventsRate %
Age < 654844539.9
Male4897323.2
Centre B2428533.2
Control16211036.5
Centre B8714528.5
Age ≥ 652745225.2
Centre B1765322.1
TABLE 1: Adverse events
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Kaplan–Meier curve for surgical site infection
Shown for children with asthma; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Change in surgical site infection
Shown for children with asthma; error bars are 95% confidence intervals.

The adjusted odds ratio was 0.44 (95% CI 0.38 to 0.68). Effects were consistent across prespecified subgroups.

1794 participants were included (median age 82 years). 1909 participants were included (median age 50 years). 3079 participants were included (median age 33 years). Effects were consistent across prespecified subgroups.